HBI Deals+Insights / News

Is IDH rethinking its IPO?

Egyptian lab group, Integrated Diagnostics holdings, could be reconsidering the structure of its IPO. IDH sold a 21% stake to an unnamed European investor before Christmas said well-placed sources.

We would welcome your thoughts on this story. Email your views to Max Hotopf or call 0207 183 3779.